Improving Compliance of BCG Immunotherapy: Practical Approaches to Managing Side- Effects  Pascal Rischmann  European Urology Supplements  Volume 5, Issue 10, Pages 660-662 (July 2006) DOI: 10.1016/j.eursup.2006.05.004 Copyright © 2006 Terms and Conditions

Fig. 1 Percentage of patients with at least one class 2 adverse event after instillations four through six. European Urology Supplements 2006 5, 660-662DOI: (10.1016/j.eursup.2006.05.004) Copyright © 2006 Terms and Conditions

Fig. 2 Percentage of patients with at least one class 3 adverse event between instillations one and nine. European Urology Supplements 2006 5, 660-662DOI: (10.1016/j.eursup.2006.05.004) Copyright © 2006 Terms and Conditions